B2M and Miyoshi myopathy: To investigate whether combining anti-β2M mAbs and BTZ enhances the anti-MM effects of BTZ in BTZ-resistant MM cells, we used BTZ-sensitive (KAS-6.wt and OPM-2.wt) and BTZ-resistant (KAS-6.BR and OPM-2.BR) MM cells [31].